Trial Profile
A multiple dose, pharmacokinetic study comparing different regimens of testosterone given as intranasal Nasobol in hypogonadal men in comparison to testosterone levels in normal healthy male volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Mattern Pharmaceuticals
- 29 Mar 2018 Phase 2 has been changed to phase 1.
- 03 May 2012 Actual patient number added 32 according to ClinicalTrials.gov.
- 03 May 2012 Actual end date changed from Dec 2008 to Mar 2009 added as reported by ClinicalTrials.gov.